National Laboratory-based Surveillance System for Antimicrobial Resistance: a Successful Tool to Support the Control of Antimicrobial Resistance in the Netherlands

Overview

Journal Euro Surveill

Specialty Infectious Diseases

Date 2017 Nov 23

PMID 29162208

Citations 30

Authors

Wieke Altorf-van der Kuil

Annelot F Schoffelen

Sabine C De Greeff

Steven Ft Thijsen

H Jeroen Alblas

Daan W Notermans

Anne Lm Vlek

Marianne Ab van der Sande

Tjalling Leenstra

Affiliations

Soon will be listed here.

Abstract

An important cornerstone in the control of antimicrobial resistance (AMR) is a well-designed quantitative system for the surveillance of spread and temporal trends in AMR. Since 2008, the Dutch national AMR surveillance system, based on routine data from medical microbiological laboratories (MMLs), has developed into a successful tool to support the control of AMR in the Netherlands. It provides background information for policy making in public health and healthcare services, supports development of empirical antibiotic therapy guidelines and facilitates in-depth research. In addition, participation of the MMLs in the national AMR surveillance network has contributed to sharing of knowledge and quality improvement. A future improvement will be the implementation of a new semantic standard together with standardised data transfer, which will reduce errors in data handling and enable a more real-time surveillance. Furthermore, the scientific impact and the possibility of detecting outbreaks may be amplified by merging the AMR surveillance database with databases from selected pathogen-based surveillance programmes containing patient data and genotypic typing data.

Citing Articles

Dynamic association of antimicrobial resistance in urinary isolates of and between primary care and hospital settings in the Netherlands (2008-2020): a population-based study.

Martinez E, Verbon A, Schoffelen A, Altorf-van der Kuil W, van Rosmalen J Lancet Reg Health Eur. 2025; 50():101197.

PMID: 39850254 PMC: 11755011. DOI: 10.1016/j.lanepe.2024.101197.

Nosocomial transmission of NDM-1-containing Klebsiella pneumoniae ST147 in a Dutch pediatric oncology center associated with patients from Ukraine.

Smit W, Wunderink H, Kluytmans J, Tissing W, van Dijkhuizen E, Loeffen Y BMC Infect Dis. 2024; 24(1):1460.

PMID: 39716112 PMC: 11667838. DOI: 10.1186/s12879-024-10368-2.

Temporal trends in antimicrobial resistance of medically important pathogens on Curaçao.

Klein Klouwenberg P, Dos Santos C, van de Wetering D, Provacia L Antimicrob Resist Infect Control. 2024; 13(1):151.

PMID: 39696523 PMC: 11656555. DOI: 10.1186/s13756-024-01499-x.

Reducing antimicrobial use in livestock alone may be not sufficient to reduce antimicrobial resistance among human infections: an ecological study in the Netherlands.

Deng H, Chaname Pinedo L, Meijs A, Sanders P, Veldman K, Brouwer M Epidemiol Infect. 2024; 152:e148.

PMID: 39601656 PMC: 11626456. DOI: 10.1017/S0950268824001511.

Attribution of invasive group A streptococcal infections (iGAS) to predisposing viral infections, the Netherlands, 2010 to 2023.

de Gier B, van de Kassteele J, van Asten L, Schoffelen A, Hooiveld M, Te Wierik M Euro Surveill. 2024; 29(40).

PMID: 39364598 PMC: 11451131. DOI: 10.2807/1560-7917.ES.2024.29.40.2300739.

References

Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, Stratchounski L . European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect. 2004; 10(4):349-83. DOI: 10.1111/j.1198-743X.2004.00887.x. View

Houben A, Oostdijk E, van der Voort P, Monen J, Bonten M, Van der Bij A . Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands. J Antimicrob Chemother. 2013; 69(3):797-804. DOI: 10.1093/jac/dkt416. View

Rempel O, Laupland K . Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Epidemiol Infect. 2009; 137(12):1665-73. DOI: 10.1017/S0950268809990100. View

Shannon K, French G . Antibiotic resistance: effect of different criteria for classifying isolates as duplicates on apparent resistance frequencies. J Antimicrob Chemother. 2001; 49(1):201-4. DOI: 10.1093/jac/49.1.201. View

Koningstein M, van der Bij A, de Kraker M, Monen J, Muilwijk J, De Greeff S . Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands. PLoS One. 2014; 9(1):e86634. PMC: 3904917. DOI: 10.1371/journal.pone.0086634. View

Vlek A, Frentz D, Haenen A, Bootsma H, Notermans D, Frakking F . Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014. Eur J Clin Microbiol Infect Dis. 2016; 35(7):1089-96. DOI: 10.1007/s10096-016-2636-6. View

Liu Y, Wang Y, Walsh T, Yi L, Zhang R, Spencer J . Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2015; 16(2):161-8. DOI: 10.1016/S1473-3099(15)00424-7. View

Van der Bij A, Frentz D, Bonten M . Gram-positive cocci in Dutch ICUs with and without selective decontamination of the oropharyngeal and digestive tract: a retrospective database analysis. J Antimicrob Chemother. 2015; 71(3):816-20. DOI: 10.1093/jac/dkv396. View

Schwaber M, De-Medina T, Carmeli Y . Epidemiological interpretation of antibiotic resistance studies - what are we missing?. Nat Rev Microbiol. 2004; 2(12):979-83. DOI: 10.1038/nrmicro1047. View

10.

Leverstein-van Hall M, Waar K, Muilwijk J, Cohen Stuart J . Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli. J Antimicrob Chemother. 2013; 68(11):2636-40. DOI: 10.1093/jac/dkt218. View

11.

Leclercq R, Canton R, Brown D, Giske C, Heisig P, MacGowan A . EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2011; 19(2):141-60. DOI: 10.1111/j.1469-0691.2011.03703.x. View

12.

van der Steen M, Leenstra T, Kluytmans J, van der Bij A . Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012. PLoS One. 2015; 10(9):e0138088. PMC: 4575062. DOI: 10.1371/journal.pone.0138088. View

13.

Van der Bij A, van Dijk K, Muilwijk J, Thijsen S, Notermans D, de Greeff S . Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia. Clin Microbiol Infect. 2012; 18(11):E466-72. DOI: 10.1111/j.1469-0691.2012.03996.x. View